Your Brain Is Glowing, and Scientists Can't Figure Out Why
But life also generates its own light—and not just the bioluminescence of glowworms and lamp-headed anglerfish or the radiation produced by heat. In a phenomenon scientists refer to as ultraweak photon emissions (UPEs), living tissues emit a continuous stream of low-intensity light, or biophotons. Scientists think that this light comes from the biomolecular reactions that generate energy, which create photons as by-products. The more energy a tissue burns, the more light it gives off—which means, of our body's tissues, our brain should glow brightest of all.
In a new study published in the journal iScience, researchers detected biophotons emitted by the human brain from outside the skull for the first time. What's more, emissions of biophotons from the brain changed when participants switched between different cognitive tasks—though the relationship between brain activity and biophoton emissions was far from straightforward. The study authors think this may be hinting at a deeper role these particles of light might be playing in the brain.
[Sign up for Today in Science, a free daily newsletter]
On some level, all matter emits photons. That's because everything has a temperature above absolute zero and radiates photons as heat, often with longer wavelengths (infrared light) than can be seen with our eyes. UPEs are orders of magnitude more intense than this thermal radiation, with wavelengths in the visible or near-visible light range of the electromagnetic spectrum. As living cells generate energy through metabolism, they create oxygen molecules with excited electrons as by-products. When these worked-up electrons return to a lower energy state, they emit photons through a process called radiative decay.
Researchers studying biological tissues, including neurons in petri dishes, can detect this as a weak but continuous stream of light—from a few photons to several hundred photons per square centimeter each second. 'Scaling this up to humans, we wanted to know if those photons might be involved in some information processing or propagation [in the brain],' says senior author Nirosha Murugan, a biophysicist at Wilfrid Laurier University in Ontario.
Scientists have been proposing that biophotons play a role in cellular communication for at least a century. In 1923 Alexander Gurwitsch conducted experiments where he showed that photon-blocking barriers placed between onion roots could prevent the plant from growing. In the past few decades, a handful of studies have added weight to the possible role biophotons play in cellular communication, which influences an organism's growth and development.
With this work in mind, Murugan and her team wanted to see if they could detect hints of this phenomenon at the level of the human brain. First, they needed to see if they could measure UPEs emitted by a working brain from outside the skull. In a blacked out room, 20 participants wore head caps studded with electroencephalography (EEG) electrodes to measure the brain's electrical activity. Photon-amplifying tubes to detect UPEs were positioned around their head. The photon detectors were clustered over two brain regions: the occipital lobes in the back of the brain, which are responsible for visual processing, and temporal lobes on each side of the brain, which are responsible for auditory processing. To distinguish brain UPEs from background levels of photons in the room, the team also set up separate UPE detectors facing away from the participants.
'The very first finding is that photons are coming out of the head—full stop. It's independent, it's not spurious, it's not random,' Murugan says.
Next, she wanted to see if the intensity of these emissions would change depending on what sort of cognitive task people were performing. Because the brain is such a metabolically expensive organ, she reasoned that UPE intensity should increase when people were engaged in tasks that required more energy, such as visual processing. This is roughly what happens to neurons in a dish—more neural activity means more UPE emissions.
But while biophotons coming from participants' heads could be easily distinguished from background levels of photons in the room, increased EEG activity in a given brain region didn't result in higher levels of biophotons being captured by the closest detector. Clearly, something changes when you move from a few cells on a petri dish to a living brain. 'Maybe [UPEs] are not getting picked up by our detector because they could be getting used or absorbed or scattered within the brain,' Murugan suggests. The researchers did find, however, that changes in the UPE signals came only when participants changed cognitive tasks, such as opening or closing their eyes, suggesting some link between brain processing and the biophotons it emits.
This leaves researchers with more questions than answers about what these UPEs are doing in the brain. 'I think this is a very intriguing and potentially groundbreaking approach [for measuring brain activity, though] there are still many uncertainties that need to be explored,' says Michael Gramlich, a biophysicist at Auburn University, who was not involved in the new study. 'The essential question to address,' he says, is whether 'UPEs are an active mechanism to alter cognitive processes or if UPEs simply reinforce more traditional mechanisms of cognition.'
Daniel Remondini, a biophysicist at the University of Bologna in Italy, points to another open question: 'How far can these photons travel inside biological matter?" The answer could shed some light on the lack of clear relationship between brain activity and photon detections in different regions, he says.
To answer these new questions, Murugan and her team want to use more precise sensor arrays to find where in the brain these photons are coming from. Scientists at the University of Rochester are also developing nanoscale probes to determine whether nerve fibers can transmit biophotons.
Even if our brain's steady glow doesn't play a role in how it works, the technique of measuring biophotons alongside electrical signals—what Murugan and her colleagues call photoencephalography—could still one day be a useful way to noninvasively measure brain states. 'I suspect the technique will become widely adopted in the coming decades even if the theory that UPEs support cognition proves not to be true,' Gramlich says.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fast Company
8 minutes ago
- Fast Company
The fellowship offering job-hunting grads an AI training lifeline
In early March, Volkan Çinar, a chemistry postdoc at MIT, received an email recruiting him to train AI models. Çinar studies carbon-carbon bonds formation in graphene. Given the stiff competition for jobs in academia, Çinar was no longer sure if his dream of working in academia made sense. So he was receptive to the email's pitch. The email came from Handshake, the job search platform which connects 18 million students from 1,600 higher ed institutions to career opportunities, introducing its new MOVE (Model Validation Expert) Fellowship. The new program gives Handshake an entrée into the high end of AI model training, the hot sector that's seen Meta acquire a 49% stake in Scale for more than $14 billion and Surge bootstrap itself to $1 billion in revenue. For talent like Çinar, MOVE offers better money than teaching and comes with AI training. 'I'd never considered working in AI,' Çinar says. 'But given that I'm exploring other positions, I thought I'd give it a try,' even if it meant the risk of paving the road for AI models to take over his field. What to expect from the program The Fellowship's acceptance rate and pay range How to make yourself competitive for an AI gig A better way to source expert talent for AI labs
Yahoo
39 minutes ago
- Yahoo
Want to protect your brain as you age? Science says to start with this routine
When you buy through links on our articles, Future and its syndication partners may earn a commission. If you're trying to stay healthy into your 60s and beyond, there's good news. A new study suggests you don't need extreme workouts or complicated diets to support your brain. Just a consistent routine and a bit of support, like coaching or regular social connection, can go a long way The research, published in JAMA, followed more than 2,000 adults aged 60 to 79 who were at risk of dementia and cognitive decline. Over the course of two years, participants were encouraged to move more, stay socially connected, and manage their heart health. They were also advised to eat well using the brain-friendly MIND diet. This diet emphasizes leafy greens, berries, nuts, whole grains, and fish while limiting red meat and processed foods.. One group followed a structured program with coaching and regular check-ins. The other group was given the same advice but had to make the changes on their own. A little structure made a big difference At the end of the study, both groups showed improvements. However, those who received structured support experienced greater gains in memory, focus, and processing speed. This support included regular coaching, group activities, goal-setting, and check-ins that helped keep participants motivated and accountable. The benefits were especially noticeable in people who had lower cognitive scores at the start. This suggests that healthy habits do matter, but it is the routine and accountability, having someone or something to help you stay on track, that makes those habits stick and leads to better results. For readers, this does not mean you need a personal coach or expensive program. Simple ways to create support include joining a local walking or exercise group, setting reminders or using apps to track your goals, partnering with a friend or family member for regular check-ins, or signing up for community classes or social clubs that focus on wellness. What this means for you The takeaway? You don't need to overhaul your lifestyle overnight. Building a simple structure, like joining a walking group or using an app to track your goals, can make it easier to follow through and see the benefits. And if you're looking to get started, moving a little more each day is a great first step. Whether that means walking with a friend or heading out for a short jog, our expert-tested list of the best running shoes can help you find the right pair. More from Tom's Guide Forget hour-long workouts — new study says this 5-minute routine improves your strength and mental health Hate sit-ups? Study shows this is the only activity you need to strengthen your core This mobility test takes just seconds — and it could predict how well you'll age
Yahoo
42 minutes ago
- Yahoo
Could a single shot at birth shield kids from HIV for years?
There's potentially exciting news from a trial conducted in monkeys: A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at least three years. Of course, studies conducted in animals don't always pan out in humans. But scientists say that if it does, it could save the lives of babies and children still imperiled by HIV. The study authors estimate that more than 100,000 children worldwide (largely in subSaharan Africa) are believed to contract HIV soon after birth, primarily via breastfeeding with an HIV+ mother. "Nearly 300 children are infected with HIV each day," said lead author Dr. Amir Ardeshir, associate professor of microbiology and immunology at the Tulane National Primate Research Center in New Orleans. "This approach could help protect newborns in high-risk areas during the most vulnerable period of their lives." His team published its findings July 30 in Nature. It noted that the new work hinges on the notion that in the first few weeks of a primate's life -- humans are primates, too -- the body's immune system is naturally more tolerant of "invaders," including gene therapies. The research focused on a tried-and-true form of HIV-fighting gene therapy. It works by programming cells to continuously produce HIV-fighting antibodies. The gene therapy was piggybacked onto a harmless adeno-associated virus (AAV) to help deliver it to the muscle cells of newborn rhesus macaques. Muscle cells were chosen because they are particularly long-lived, Ardeshir's team explained. The gene therapy instructs these cells to produce broadly neutralizing antibodies, or bNAbs, which are capable of neutralizing multiple strains of HIV. It's not the first time bNAbs have been used in gene therapy to fight HIV. However, in prior trials repeat injections were required to keep the immune system vigilant. In the new trial, "we turn these muscle cells -- which are long-lived -- into micro factories that just keep producing these antibodies," Ardeshir explained. When such an approach is used in older monkeys, however, the animals' robust immune systems turn against the therapy, shutting it down. That didn't happen when Ardeshir's team introduced it during a macaque's first few weeks of life. All of the monkeys who got a single shot of bNAbs therapy soon after birth were shielded from infection with HIV for at least three years, with no need for a booster. Tulane researchers said that's roughly the equivalent of a treatment that could ward off HIV in humans deep into adolescence. If the gene therapy was delivered even a bit later -- 8 to 12 weeks after birth -- the young monkey's more developed immune system swung into action to fight it, eroding its effectiveness. Giving the shot soon after birth seemed key, Ardeshir said. "This is a one-and-done treatment that fits the critical time when these mothers with HIV in resource-limited areas are most likely to see a doctor," he noted in a Tulane news release. "As long as the treatment is delivered close to birth, the baby's immune system will accept it and believe it's part of itself." Will it work in human babies? That's not entirely clear, since it's possible infants might be less amenable than monkeys to therapies that are delivered via AAV, the team said. The monkey trial also used only one strain of simian-human immunodeficiency virus, which is similar in some ways to HIV but may not reflect the variety of circulating strains of HIV strains. Still, the research team is hopeful. Giving families a one-shot preventive tool to protect their children would be especially useful in areas where access to repeat medical treatments can be tough, the researchers said. "Nothing like this was possible to achieve even 10 years ago," Ardeshir said. "This was a huge result, and now we have all the ingredients to take on HIV." More information Find out more about HIV and AIDS at the U.S. Centers for Disease Control and Prevention (CDC). SOURCE: Tulane University, news release, July 30, 2025 Copyright © 2025 HealthDay. All rights reserved.